Kawasaki, Japan

Yuichi Gyotoku

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuichi Gyotoku. Retrieved from https://idiyas.com/inventor/yuichi-gyotoku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuichi Gyotoku: Innovator in Antiarrhythmic Agents

Introduction

Yuichi Gyotoku is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic agents. His innovative work has led to the creation of a unique piperidine compound that holds promise for medical applications.

Latest Patents

Gyotoku holds a patent for "Piperidine compounds and their use as antiarrhythmic agents." This patent describes a piperidine derivative characterized by a general formula that includes various specified aromatic-containing groups and hetero atom-containing groups. The derivatives are particularly useful in treating arrhythmias, showcasing Gyotoku's commitment to advancing medical science.

Career Highlights

Yuichi Gyotoku is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to focus on innovative research and development, contributing to the company's reputation for excellence in pharmaceutical advancements.

Collaborations

Throughout his career, Gyotoku has collaborated with esteemed colleagues such as Akira Hirasawa and Masataka Shoji. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Yuichi Gyotoku's contributions to the development of antiarrhythmic agents exemplify his dedication to innovation in pharmaceuticals. His work continues to impact the medical community positively, paving the way for future advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…